Voyager Therapeutics Inc (VYGR)
Cost of Revenue
$0.00
TTM · Period ending: · USD
VYGR Cost of Revenue
Latest reported$0.00period ending
Latest reported$0.00period ending
VYGR TTM Cost of Revenue ($8.90M → $0.00)
TTM cost of revenue
High-resolution chart · PNG
VYGR cost of revenue history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 1,196,000 | |
| 2,531,000 | |
| 28,394,000 | |
| 50,379,000 | |
| 67,751,000 | |
| 80,967,000 | |
| 74,441,000 | |
| 64,983,000 | |
| 60,764,000 | |
| 60,233,000 | |
| 58,810,000 | |
| 65,788,000 | |
| 73,785,000 | |
| 81,761,000 | |
| 88,886,000 | |
| 98,804,000 | |
| 108,751,999 | |
| 123,306,999 | |
| 128,044,999 | |
| 123,941,999 | |
| 116,479,000 | |
| 96,842,000 | |
| 83,697,000 | |
| 74,884,000 | |
| 64,906,000 | |
| 61,319,000 | |
| 64,248,000 | |
| 63,041,000 | |
| 62,260,000 | |
| 61,656,000 | |
| 52,404,000 | |
| 47,588,000 | |
| 42,248,000 | |
| 38,745,000 | |
| 34,917,000 | |
| 30,888,000 | |
| 27,679,000 | |
| 21,419,000 | |
| 17,337,000 | |
| 12,989,000 | |
| 8,898,000 |